Leitner Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEITNER PHARMS, and what generic and branded alternatives to LEITNER PHARMS drugs are available?
LEITNER PHARMS has one approved drug.
Summary for Leitner Pharms
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Leitner Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leitner Pharms | SYNALGOS-DC-A | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 089166-001 | May 14, 1986 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
